Aminopyrimidine compounds and pharmaceuticals containing them

Abstract

The invention relates to novel compounds acting as modulators of aryl hydrocarbon receptors (AhR), pharmaceuticals containing compounds modulated by AhR, or for the prevention or treatment of diseases, disorders, or conditions caused by the activity of AhR, as active ingredients, and thus, which may be useful as medicines for the prevention or treatment of diseases, disorders, or conditions caused by the activity of AhR, especially cancer, cancerous conditions, tumors, fibrosis, conditions with impaired immune response, etc.